Final results of the DisCoVeRy trial of remdesivir for patients admitted to hospital with COVID-19

Lancet Infect Dis. 2022 Jun;22(6):764-765. doi: 10.1016/S1473-3099(22)00295-X.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adenosine Monophosphate* / analogs & derivatives
  • Adenosine Monophosphate* / therapeutic use
  • Alanine* / analogs & derivatives
  • Alanine* / therapeutic use
  • COVID-19 Drug Treatment*
  • Clinical Trials as Topic
  • Hospitalization
  • Humans

Substances

  • remdesivir
  • Adenosine Monophosphate
  • Alanine